Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.

Authors

null

Yuko Takahashi

Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan

Yuko Takahashi , Shinsuke Sasada , Naoto Kondo , Hiroya Hashimoto , Kaori Terata , Yasuaki Sagara , Yoichi Naito , Kumiko Kida , Takayuki Ueno , Keisei Anan , Akihiko Suto , Chizuko Kanbayashi , Mina Takahashi , Rikiya Nakamura , Toshiyuki Ishiba , Michiko Tsuneizumi , Seiichiro Nishimura , Fumikata Hara , Tadahiko Shien , Hiroji Iwata

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 538)

DOI

10.1200/JCO.2023.41.16_suppl.538

Abstract #

538

Poster Bd #

368

Abstract Disclosures